Related Experiment Video
Updated: Sep 11, 2025
06:28
Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
Published on: June 4, 2020
6.9K
The Hypercoagulable State: A Study of Clot Waveform Analysis, Thrombin Generation, and Clot Scanning Electron
Archives of Pathology & Laboratory Medicine
|August 11, 2025
Summary
Clot waveform analysis (CWA) detects hypercoagulable states, similar to thrombin generation assays. This method reveals differences in clot texture, offering new insights into clotting disorders.
Area of Science:
- Hematology
- Medical Diagnostics
Background:
- Clot waveform analysis (CWA) offers detailed insights into clotting processes for standard tests like prothrombin time (PT) and activated partial thromboplastin time (aPTT).
- Optical detection systems in coagulometers capture data for CWA without additional reagent costs.
Purpose of the Study:
- To determine if CWA can identify hypercoagulable states across various clinical conditions, mirroring the capabilities of thrombin generation (TG) assays.
- To investigate textural differences in in vitro clots using scanning electron microscopy (SEM).
Main Methods:
- Collected data from 191 patients including PT INR, aPTT ratio, CWA, D-dimer, fibrinogen, von Willebrand factor (vWF:Ag, vWF:RiCo), TG assays, and SEM clot imaging.
- Performed texture analysis on SEM images using MATLAB software.
Main Results:
- Patients with COVID-19, systemic sclerosis, and high or low Padua Prediction Scores (PPS) exhibited elevated CWA, fibrinogen, D-dimer, and TG levels compared to controls.
- SEM revealed thicker in vitro clots in these patient groups.
- COVID-19 patients showed the highest vWF:Ag and vWF:RiCo levels.
Conclusions:
- CWA effectively detects hypercoagulable states in patients at risk for clotting, comparable to TG assays.
- SEM analysis identified distinct in vitro clot textures, potentially illuminating underlying pathologies.
- CWA, though currently a research tool, may evolve into a clinically valuable test, augmenting PT and aPTT results.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
903
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
903
01:30Venous Thrombosis I: Introduction
40
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
40
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
35
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
35
01:09Coagulation
7.4K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
7.4K
01:29Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
01:20Extrinsic and Intrinsic Pathways of Hemostasis
9.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.2K